GPCR FY 2024 Earnings — Structure Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

GPCRStructure Therapeutics Inc.

$3B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$158M

Net Income

-$123M

EPS (Diluted)

$-2.34

Cash Flow

Operating Cash Flow

-$117M

Free Cash Flow

-$118M

Stock-Based Comp.

$19M

Balance Sheet

Total Assets

$903M

Total Liabilities

$38M

Stockholders' Equity

$865M

Cash & Equivalents

$170M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$158M	-$103M	-54.0%
Net Income	-$123M	-$90M	-36.7%